Logo image
Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium
Journal article   Open access   Peer reviewed

Inhibition of DNA-dependent protein kinase catalytic subunit boosts rAAV transduction of polarized human airway epithelium

Kang Ning, Xiujuan Zhang, Zehua Feng, Siyuan Hao, Cagla Aksu Kuz, Fang Cheng, Soo Yuen Park, Shane McFarlin, John F. Engelhardt, Ziying Yan, …
Molecular therapy. Methods & clinical development, Vol.31, 101115
12/2023
DOI: 10.1016/j.omtm.2023.101115
PMCID: PMC10568418
PMID: 37841417
url
https://doi.org/10.1016/j.omtm.2023.101115View
Published (Version of record) Open Access

Abstract

Adeno-associated virus (AAV)2.5T was selected from the directed evolution of AAV capsid library in human airway epithelia. This study found that recombinant (r)AAV2.5T transduction of well-differentiated primary human airway epithelia induced a DNA damage response (DDR), characterized by the phosphorylation of replication protein A32 (RPA32), histone variant H2AX (H2A histone family member X), and all three phosphatidylinositol 3-kinase-related kinases (PIKKs): Ataxia-telangiectasia mutated kinase (ATM), Ataxia telangiectasia and Rad3-related kinase (ATR), and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). While suppressing the expression of ATR by a specific pharmacological inhibitor or targeted gene silencing inhibited rAAV2.5T transduction, DNA-PKcs inhibition or targeted gene silencing significantly increased rAAV2.5T transgene expression. Notably, DNA-PKcs inhibitors worked as a “booster” to further increase rAAV2.5T transgene expression after treatment with doxorubicin and did not compromise epithelial integrity. Thus, our study provides evidence that DDR is associated with rAAV transduction in well-differentiated human airway epithelia, and DNA-PKcs inhibition has the potential to boost rAAV transduction. These findings highlight that the application of DDR inhibition-associated pharmacological interventions has the potential to increase rAAV transduction and thus to reduce the required vector dose. [Display omitted]

Details

Metrics

Logo image